Monmouth Junction, NJ, November 4, 2009: The New Jersey Commission on Science and Technology recently awarded a Post-Doctoral Fellowship Grant to Amita Oka, Ph.D. in Microbiology from Rutgers University, to work with ProFACT Proteomics, Inc. The grant will fund Dr. Oka’s cross-disciplinary research in Microbiology and Proteomics.
“We are very happy to have Dr. Oka bring her energy and expertise to ProFACT”, stated David Golub, CEO.
Dr Oka’s work will generate research biomarkers for the Microbiologist with benefits similar to those which biomarkers have for medicine. In the case of Biopharma, proteomic biomarkers look into the protein constellation of an organism for an indication of the presence or progression of a disease. For the Microbiologist, a proteomic marker may help identify a particular functioning microorganism among a constellation of microbes.
Dr. Oka will initially reinforce and amplify the Company’s applications development program, providing new bioassays and enhanced Rational Proteome Prospecting™ to add value to the Company’s current Molecular Profiling Service and Collaborations offerings.
In the longer term, the addition of mixed genome proteome prospecting through new Microbiology applications will permit the Company to seek business development opportunities in the Agriculture, Environmental Remediation and Energy industries.
About ProFACT Proteomics, Inc.
ProFACT Proteomics, Inc. is a privately held early-stage corporation which applies its enabling proprietary Proteomics technology, for development of therapeutics, diagnostics and personalized medicine, principally for cancer. Through partnership and service agreements, ProFACT offers SeraFILE™ for Functional Proteomics in four key areas for Drug and Biomarker development: 1) reduction of protein complexity and sub-proteome creation; 2) Rational Proteome Prospecting™, to enrich and isolate functional activity; 3) Conformerics™, to generate drug screening assays based on enzyme sub-states or conformers; and 4) Rational Genome to Proteome Prospecting™, for prospecting into protein expression based on gene expression data.
For more information, contact:
Matthew Kuruc
ProFACT Proteomics, Inc.
1 Deer Park Drive, Suite P
Monmouth Junction, NJ 08852
732-230-3021
mkuruc@profactproteomics.com
